Improvements in psoriasis within different body regions vary over time following treatment with ixekizumab.

CONCLUSIONS: Within 12 weeks of ixekizumab treatment, all signs of psoriasis across all body regions reached clinically meaningful improvements, with the head/neck and trunk responding quicker than psoriasis of the arms and legs, especially with reduced scaling and thickness. PMID: 28792259 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/28792259?dopt=Abstract

Source: Journal of Dermatological Treatment - August 11, 2017 Category: Dermatology Tags: J Dermatolog Treat Source Type: research

More News: Dermatology | Enbrel | Psoriasis | Skin